Shandong Weigao proposes charter amendments and H share full circulation

Shandong Weigao Group Medical Polymer Company Limited announced proposed amendments to its Articles of Association, aligning them with new Company Law effective July 1, 2024, and CSRC guidelines issued March 28, 2025. These changes also incorporate flexibility for treasury shares and updated Listing Rules for paperless meetings and electronic voting. The board believes these amendments are in the best interests of the company and its shareholders.

The company also plans an H Share Full Circulation, converting 48,300,000 unlisted shares, representing approximately 1.06% of total issued shares, into H shares. This initiative, subject to CSRC and Stock Exchange approvals, follows guidelines from November 2019 and August 2023. The company will apply for listing and dealing permission for these converted H shares on the Main Board of the Stock Exchange.

Shareholders will convene an extraordinary general meeting (EGM) to consider and approve these proposed amendments and the related authorization. The H Share Full Circulation is contingent on CSRC approval and the Stock Exchange’s listing consent. Shareholders and potential investors are advised to exercise caution.